Open Access
Issue
E3S Web Conf.
Volume 308, 2021
2021 6th International Conference on Materials Science, Energy Technology and Environmental Engineering (MSETEE 2021)
Article Number 02021
Number of page(s) 10
Section Environmental Ecology and Biochemical Testing
DOI https://doi.org/10.1051/e3sconf/202130802021
Published online 27 September 2021
  1. J.V., Lazarus, et al., NAFLD — sounding the alarm on a silent epidemic. Nature Reviews Gastroenterology & Hepatology, 2020. 17(7). [Google Scholar]
  2. W.G. Lai-Hung, and W.V. Wai-Sun, Non-alcoholic fatty liver disease in Asia: How is it different from the West? Journal of gastroenterology and hepatology, 2019. 34(8). [Google Scholar]
  3. EASL. Disease (NAFLD) becoming the most common cause of liver disease in Europe. . [cited 2021 Jan 23]; Available from: https://easl.eu/press-release/easl-nafld-obesity-epidemic-europe/. [Google Scholar]
  4. W.-K Seto, and M.-F. Yuen, Nonalcoholic fatty liver disease in Asia: emerging perspectives. Journal of Gastroenterology, 2017. 52(2). [Google Scholar]
  5. C.D Byrne, and G. Targher, NAFLD: A multisystem disease. Journal of Hepatology, 2015. 62(1). [Google Scholar]
  6. S.L. Friedman, et al., Mechanisms of NAFLD development and therapeutic strategies. Nature Medicine, 2018. 24(7). [Google Scholar]
  7. T. Valeria, B. Beatrice, and F. Luigi, Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms. The journals of gerontology. Series A, Biological sciences and medical sciences, 2018. 73(3). [Google Scholar]
  8. S. Leoni, et al., Current guidelines for the management of non-alcoholic fatty liver disease:A systematic review with comparative analysis. World Journal of Gastroenterology, 2018. 24(30): p. 3361–3373. [CrossRef] [PubMed] [Google Scholar]
  9. Y. Zobair, et al., Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology (Baltimore, Md.), 2019. 69(6). [Google Scholar]
  10. P. Martin, F.M. A, and L.G. I, The roles of c-Jun NH2-terminal kinases (JNKs) in obesity and insulin resistance. The Journal of physiology, 2016. 594(2). [Google Scholar]
  11. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. The Journal of Clinical Investigation, 2005. 115(5). [PubMed] [Google Scholar]
  12. J, W.S. and A.-E.L. A, Fatty acid metabolism: target for metabolic syndrome. Journal of lipid research, 2009. 50 Suppl. [PubMed] [Google Scholar]
  13. A.J. Sanyal, et al., Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med, 2010. 362(18): p. 1675–85. [CrossRef] [PubMed] [Google Scholar]
  14. S. Kajimura, B.M. Spiegelman, and P. Seale, Brown and Beige Fat: Physiological Roles beyond Heat Generation. Cell Metabolism, 2015. 22(4). [Google Scholar]
  15. A.J. Sanyal, et al., Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology, 2001. 120(5). [Google Scholar]
  16. F. Bril, et al., Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. Hepatology, 2017. 65(4). [Google Scholar]
  17. H. Yki-Järvinen, Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. The Lancet Diabetes & Endocrinology, 2014. 2(11). [Google Scholar]
  18. J. Henao-Mejia, et al., Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature: International weekly journal of science, 2012. 482(7384). [Google Scholar]
  19. L Christopher, et al., The role of the gut microbiota in NAFLD. Nature reviews. Gastroenterology & hepatology, 2016. 13(7). [Google Scholar]
  20. T. Takuma, and F.S. L, Mechanisms of hepatic stellate cell activation. Nature reviews. Gastroenterology & hepatology, 2017. 14(7). [Google Scholar]
  21. C.-M Lăcătușu, et al., The Mediterranean Diet: From an Environment-Driven Food Culture to an Emerging Medical Prescription. International Journal of Environmental Research and Public Health, 2019. 16(6). [Google Scholar]
  22. C. Anania, et al., Mediterranean diet and nonalcoholic fatty liver disease. World Journal of Gastroenterology, 2018. 24(19): p. 2083–2094. [CrossRef] [PubMed] [Google Scholar]
  23. M, T.F., et al., Neglected features of lifestyle: Their relevance in non-alcoholic fatty liver disease. World journal of hepatology, 2016. 8(33). [Google Scholar]
  24. L. Serra-Majem, et al., Olive oil and the Mediterranean diet: beyond the rhetoric. European Journal of Clinical Nutrition, 2003. 57(Suppl). [Google Scholar]
  25. G. Buckla nd, and C. Gonzalez, Olives and Olive Oil in Health and Disease Prevention. Vol. Trends in Olive Oil Production, Supply and Consumption in Mediterranean Countries from 1961 to the Present Day. 2010. 689–698. [Google Scholar]
  26. G Anania, D. and M. Andrea. Olive oil in the Mediterranean Area: Production, Consumption and Trade.. The CIHEMA Watch letter. 2011; Available from: https://www.researchgate.net/profile/Giovanni-Anania/publication/266556780_Olive_oil_in_the_Mediterranean_Area_Production_Consumption_and_Trade/links/543404940cf2dc341daf2d43/Olive-oil-in-the-Mediterranean-Area-Production-Consumption-and-Trade.pdf. [Google Scholar]
  27. K. Kenichi, et al., Growing Olive Oil Export and Intra-Industry Trade in Mediterranean Countries: Application of Gravity Model. Sustainability, 2020. 12(17). [Google Scholar]
  28. J Lillo,. World olive oil market. International Olive Council 2011; Available from: https://www.caixabank.es/deployedfiles/empresas/Estaticos/pdf/AgroBank/PonenciaSrLillo.pdf [Google Scholar]
  29. (FAO), U.N.F.a.A.O. Vegetables – food supply quantity (kg/capita/year). Our world in data. 2020; Available from: https://ourworldindata.org/grapher/vegetable-consumption-per-capita?tab=chart&time=earliest..latest&country=Asia~Eastern%20Europe~Europe%2C%20Western~Europe~JPN~Northern%20Europe~Southern%20Europe~USA. [Google Scholar]
  30. F.S. Marinho, , et al., Dietary patterns in Brazilian patients with nonalcoholic fatty liver disease: a cross-sectional study. Clinics (Sao Paulo, Brazil), 2013. 68(1). [Google Scholar]
  31. The Prevalence of Nonalcoholic Fatty Liver Disease and its Association with Lifestyle/dietary Habits among University Faculty and Staff in Chengdu. Biomedical and Environmental Sciences, 2012. 25(04): p. 383–391. [Google Scholar]
  32. K.A McManus, practical guide to the Mediterranean diet.. 2019; Available from: https://www.health.harvard.edu/blog/a-practical-guide-to-the-mediterranean-diet2019032116194#:~:text=Eat%20less%20meat.,a nd%20fresh%20fish%20are%20fine. [Google Scholar]
  33. S. Zelber-Sagi, et al., High red and processed meat consumption is associated with non-alcoholic fatty liver disease and insulin resistance. Journal of Hepatology, 2018. 68(6). [Google Scholar]
  34. R.M Ritchie H.,. Meat and Dairy Production.. 2017; Available from: https://ourworldindata.org/meat-production. [Google Scholar]
  35. Echosens North America. Waltham: Echosens 2020 [cited 2021 Mar 25]; Available from: https://echosens.us/echosens-aligns-with-the-fatty-liver-foundation/. [Google Scholar]
  36. E. Chris, et al., Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. Journal of hepatology, 2018. 69(4). [Google Scholar]
  37. G. Xiaojun, et al., Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990–2017: a population-based observational study. BMJ open, 2020. 10(8). [Google Scholar]
  38. S. Zelber-Sagi, F. Salomone, and L. Mlynarsky, The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms. Liver International, 2017. 37(7): p. 936–949. [Google Scholar]
  39. Italians lose Appetite for healthy Mediterranean diet. The International Foundation of Mediterranean Diet (IFMeD) 2016; Available from: https://www.ifmed.org/italians-lose-appetite-for-healthy-mediterranean-diet/#:~:text=It%20has%20long%20been%20lauded, olive%20oil%2C%20pasta%20and%20fish [Google Scholar]
  40. J.V. Lazarus, , et al., A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe. Journal of Hepatology, 2020. 72(1). [Google Scholar]
  41. S. Ashtari, M.A. Pourhoseingholi, and M.R. Zali, Non-alcohol fatty liver disease in Asia:Prevention and planning. World Journal of Hepatology, 2015. 7(13): p. 1788–1796. [Google Scholar]
  42. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups. Digestive and Liver Disease, 2015. 47(12). [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.